Skip to main content
Premium Trial:

Request an Annual Quote

Yes, But How?

While an advisory panel has recommended changes to Australia's biomedical research program, including an increase in public sector investment, ScienceInsider notes that the Australian government is considering freezing research grants as part of its austerity measures. The panel suggests that the national, state, and territory governments should devote 3 percent of their health spending on research as well as advance clinical trials and public health research and support the development of personalized medicine, among other initiatives, ScienceInsider adds.

"It's clear the review panel have got the message that there are things to be fixed," Darren Saunders, a cancer biologist at the Garvan Institute of Medical Research, tells The Conversation. "The big question is how it will be implemented — that's going to be the real challenge."

The Scan

Rare Genetic Disease Partnership

A public-private partnership plans to speed the development of gene therapies for rare genetic diseases, Stat News writes.

Approval Sought for Alzheimer's Drug

The Wall Street Journal reports Eli Lilly has initiated a rolling submission to the US Food and Drug Administration to seek approval for its drug to treat Alzheimer's disease.

DNA Barcoding Paper Retracted

Science reports that a 2014 DNA barcoding paper was retracted after a co-author brought up data validity concerns.

Nature Papers Present Genomic Analysis of Bronze Age Mummies, Approach to Study Host-Pathogen Interactions

In Nature this week: analysis finds Tarim mummies had local genetic origin, and more.